GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » Valuation Rank

Cessatech AS (FRA:8GN) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Cessatech AS Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Cessatech AS Valuation Rank Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cessatech AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » Valuation Rank
Comparable Companies
OSTO:ISOFOL OSTO:KDEV OSTO:ALZ OSTO:XINT XSAT:CURAS OSTO:CLBIO OSTO:XBRANE OSTO:NXTCL OSTO:ACE OSTO:ONCO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
CESSA:Sweden
Address
Strandvejen 60, Hellerup, DNK, DK- 2900
Website
https://www.cessatech.com
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.